ASPERGILLOSIS Angelica Westry. Symptoms A fungus ball in the lungs may cause no symptoms and may be discovered only with a chest x-ray. Or it may cause.

Slides:



Advertisements
Similar presentations
TB 101 “Basic Facts on Tuberculosis”
Advertisements

FUNGAL DISEASES IN THE RESPIRATORY , EXCRETORY & CIRCULATORY SYSTEMS
Fungal Diseases of Paranasal Sinuses
OPPORTUNISTIC FUNGAL INFECTIONS
The times.. they are a changing Dr. Hamdi Akan Ankara University Medical School Dept. of Hematology.
Fungal Diseases March 24 th, Fungi fundamentals Occupy almost every ecological niche Exist in two forms: Yeasts –Single celled Molds –Growth in.
1 Voriconazole NDAs and Empiric Antifungal Therapy of Febrile Neutropenic Patients Study 603 John H. Powers, M.D. Medical Officer Division.
ANTIFUNGAL DRUGS.
Antifungal Drugs I. Humans and fungi share a common biosynthetic pathway for sterols from squalene (via squalene 2,3 epoxidase and other enzymes) to lanosterol.
بسم الله الرحمن الرحيم Medical mycology
What is Pneumonia and How Do I Prevent it?
Launching at MMC - Aspergillus Galactomannan EIA - “Galactomannan Screening for the Early Diagnosis of Invasive Aspergillosis” Dr. Vilma M. Co / Dr. Demetrio.
Cryptococcal pneumonia and meningitis. Cryptococcus neoformans.
Viral Myocarditis.
Lower Respiratory Tract Infection. Pneumonia Common with high morbidity and mortality rates. Acute respiratory infection with focal chest signs and radiographic.
CRYPTOCOCCAL INFECTIONS IN PATIENTS WITH AIDS Stephen J. Gluckman, M.D. Botswana-UPENN Partnership.
Cryptococcal Meningitis in Patients with AIDS. Clinical Case 30-year-old male with AIDS CD4 25 cells/mm3 Gradual increasing headache for past five days.
Fungal Infections Who is at Risk Seriously ill patients being treated with Corticosteroids Antineoplastic drugs Immunosuppressive drugs Patients with.
Quick Anti-fungals By Sarah E.. Anti-fungals Name the 6 categories of anti-fungals 1.Polyenes 2.-azoles 3.Synthetic allylamines 4.Anti-metabolites 5.Echinocandins.
Aspergillosis infection
Respiratory Fungal Infections
Treatment of Aspergillosis John R. Perfect Duke University Medical Center.
Combination Antifungal Therapy By Amy Barnett, Doctor of Pharmacy Candidate University of Florida College of Pharmacy.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
The Fungus Among Us By: Katherine C. And Marissa W.
Lung cancer, like all cancers, happens with abnormal cell function. Lung cancer is a very life threatening cancer, as it tends to spread early and is.
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Mucocutaneous Candidiasis Slide Set Prepared.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Kings Coccidioidomycosis Conference: Coccidioidomycosis In Infants And Children Francesca Geertsma, MD Pediatric Infectious Diseases Consultant Kaweah.
A Fungal Disease Mr. Watt Mod 1/2/5 Fever Valley Fever.
Selection of an optimal antifungal for treatment of invasive aspergillosis: susceptibility/resistance, adverse reactions, drug interactions John Bennett,
Therapeutic management in a boy with XL-CGD complicated by invasive aspergillosis. Department of Immunology Children’s Memorial Health Institute Warsaw.
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Aspergillosis Slide Set Prepared by the AETC.
By Gabriela Arevalo.  Pneumonia is a breathing condition in which there is an infection of the lung. It invades the lungs and the bloodstream to cause.
Opportunistic Pathogens –Aspergillus species. Aspergillosis is an infection caused by Aspergillus, a common mold that lives indoors and outdoors. Most.
Hospital-acquired Invasive Aspergillosis: How Big is the Problem?
Lateral flow device (LFD) test on bronchoalveolar lavage (BAL) samples for diagnosing invasive pulmonary aspergillosis (IPA): diagnostic accuracy Single-centre.
Altered mental status post transplant 66 year-old woman h/o diabetes mellitus s/p deceased donor renal transplantation One year post transplant admit to.
Tuberculosis in Children and Young Adults
ASPERGILLOSIS Prof. Khaled H. Abu-Elteen ASPERGILLOSIS Aspergilli produce a wide variety of diseases. Like the zygomycetes, they are ubiquitous in nature.
RESPIRATORY FUNGAL INFECTION. YEASTMOULD FUNGIDIMORPHIC FUNGI OpportunisticPrimary Infectious Candidiasis (Candida and other yeast) Aspergillosis (Aspergillus.
Respiratory Fungal Infections
Systemic fungal infection (Mycosis). Candidiasis  candida albicans infection  Immune compromised Pt. 1.Skin and M.M. candidiasis 2.Ophthalmic C.  loss.
Outline of the Presentation
Empirical versus Preemptive Antifungal Therapy for High-Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial Clinical Infectious Diseases.
Timothy W. Felton, Caroline Baxter, Caroline B. Moore, Stephen A.Roberts, William W. Hope,and David W. Denning Clinical Infectious Diseases 2010; 51:1383–1391.
Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, National Institutes of Health, and HIV Medicine Association/Infectious.
EBM Journal Club GS 謝閔傑. 題目 對於治療急性壞死性胰臟炎病患有需要使用抗生 素治療嗎?
VALDEZ ET AL CLINICAL INFECTIOUS DISEASES 2011;52(6):726–735 R2 Kim Dong Hyun Decreased Infection-Related Mortality & Improved Survival in Severe Aplastic.
Fungal Peritonitis (FP) Constantinos J. Stefanidis “P. and A. Kyriakou” Children’s Hospital Athens, Greece.
Worldwide availability and pricing of antifungal drugs
Histoplasmosis.
Brielle Haas RISE Spring 2015 Dr. Gullo
Respiratory diseases caused by fungi
Pulmonary Zygomycosis
CRYPTOCOCCAL INFECTIONS IN PATIENTS WITH AIDS
Respiratory Disorders
CONCLUSIONS INTRODUCTION METHODS
Respiratory Fungal Infections
Antifungal Agents Chapter 11.
Anti-fungal agents Problem: Fungi are eukaryotes
5/23/2013 hammoud.
Y. Hicheri, G. Cook, C. Cordonnier  Clinical Microbiology and Infection 
Management of CPA Dr. Chris Kosmidis.
Y. Hicheri, G. Cook, C. Cordonnier  Clinical Microbiology and Infection 
How to bolster the antifungal pipeline
DEPARTMENT OF MEDICINE, UOM
Management of Chronic Pulmonary Aspergillosis
Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients  D. Caillot, L. Mannone,
Presentation transcript:

ASPERGILLOSIS Angelica Westry

Symptoms A fungus ball in the lungs may cause no symptoms and may be discovered only with a chest x-ray. Or it may cause repeated coughing up of blood and occasionally severe, even fatal, bleeding. A rapidly invasive Aspergillus infection in the lungs often causes cough, fever, chest pain, and difficulty breathing.

Diagnosis On chest x-ray and computed tomography pulmonary aspergillosis classically manifests as an air crescent sign. In hematologic patients with invasive aspergillosis the galactomannan test can make the diagnosis in a noninvasive way.

Treatment The drugs amphotericin B, caspofungin, flucytosine, itraconazole, voriconazole are used to treat this fungal infection. For severe cases of invasive aspergillosis a combination therapy of voriconazole and caspofungin is suggested as a first line treatment.

Outbreaks Albeit relatively rare in humans, aspergillosis is a common and dangerous infection in birds, particularly in pet parrots. Mallards and other ducks are particularly susceptible as they will often resort to poor food sources during bad weather.

Case Study To update the case-fatality rate (CFR) associated with invasive aspergillosis according to underlying conditions, site of infection, and antifungal therapy, data were systematically reviewed and pooled from clinical trials, cohort or case-control studies, and case series of >/=10 patients with definite or probable aspergillosis. Subjects were 1941 patients described in studies published after 1995 that provided sufficient outcome data; cases included were identified by MEDLINE and EMBASE searches. The main outcome measure was the CFR. Fifty of 222 studies met the inclusion criteria. The overall CFR was 58%, and the CFR was highest for bone marrow transplant recipients (86.7%) and for patients with central nervous system or disseminated aspergillosis (88.1%). Amphotericin B deoxycholate and lipid formulations of amphotericin B failed to prevent death in one-half to two-thirds of patients. Mortality is high despite improvements in diagnosis and despite the advent of newer formulations of amphotericin B. Underlying patient conditions and the site of infection remain important prognostic factors.

References Wikipedia.org Google.com Aspergillus - Aspergillus website News article in The Guardian